What factors explain the 100% increase in institutional owners and 34,146.54% portfolio allocation change for RGC?

What factors explain the 100% increase in institutional owners and 34,146.54% portfolio allocation change for RGC? AI+
Eric 01-11 Regencell Bioscience Holdings Limited Public
US:RGC

What factors explain the 100% increase in institutional owners and 34,146.54% portfolio allocation change for RGC?

Rate this post:
0
Kommentarer (1)
AI+ Standard 01-11
Dette svar blev genereret af AI. Selvom vi stræber efter nøjagtighed, kan det indeholde fejl.

The significant changes in institutional ownership for Regencell Bioscience Holdings Limited (RGC), including a 100% increase in institutional owners and a 34,146.54% change in average portfolio allocation, can primarily be attributed to a recent corporate action: a forward stock split.

Impact of Forward Stock Split

On June 13, 2025, Regencell Bioscience Holdings Limited effected a 38-for-one forward stock split. This means that for every share an investor held, they received 37 additional shares, effectively multiplying their share count by 38. The company stated that this action was intended to enhance liquidity and make the shares more accessible to investors.1

  • Increased Share Count: The stock split dramatically increased the number of shares outstanding. For institutional investors, their existing positions would have been multiplied by 38. This directly inflates the reported "institutional shares (Long)" and the "institutional value (Long)" in absolute terms, even if their percentage ownership remained constant.
  • Portfolio Allocation Change: The 34,146.54% increase in average portfolio allocation reflects the substantial increase in the value of RGC holdings within institutional portfolios following the split. If the share price adjusted proportionally, the total value of the position would remain the same, but the Fintel metric likely captures the nominal increase in shares held, or new positions taken at potentially higher prices post-split.
  • New Institutional Owners: The 100% increase in the number of institutional owners, bringing the total to 10 in the most recent quarter, suggests that the increased liquidity and accessibility post-split may have attracted new institutional investors to take positions in RGC.2

Specific Ownership Data

According to Fintel data, Regencell Bioscience Holdings Limited currently has 10 institutional owners. These institutions collectively hold 39,738 shares, with an institutional value of $6,666,000 USD.2 Notable institutional shareholders include Y-Intercept (Hong Kong) Ltd, Greenfield Savings Bank, Geode Capital Management, Llc, FNCMX - Fidelity Nasdaq Composite Index Fund, Royal Bank Of Canada, Tower Research Capital LLC (TRC), BlackRock, Inc., Farther Finance Advisors, LLC, and Morgan Stanley.2

Additionally, a 13D/A filing by Regencell (BVI) Ltd on July 11, 2025, reported a significant increase in shares held from 11,221,821 to 437,896,116, an increase of 3,802.18%, with their ownership rising to 88.60%. This entity is controlled by Mr. Yat-Gai Au, the company's founder, director, and CEO, and this change is consistent with the effects of the 38-for-one forward stock split.2

In summary, the dramatic shifts in institutional ownership metrics for RGC are primarily a consequence of the 38-for-one forward stock split, which increased the number of shares and likely enhanced the stock's appeal to a broader institutional base.

Rate this response:
0

Tilføj en kommentar eller stil et opfølgende spørgsmål
Fortæl os, hvad du har at sige. Du kan inkludere links, men ikke *bare* links. Del dine tankevækkende meninger. Brug Markdown .
Using Standard
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista